SCHEMBL31542015

SCHEMBL31542015

Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
KMT2A Q03164 3/20 0.63
KDM4E B2RXH2 3/20 0.63
GFER P55789 2/20 0.63
TP53 P04637 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
RECQL P46063 2/20 0.61
POLB P06746 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
MEN1 O00255 1/20 0.61
USP2 O75604 1/20 0.61
MAPT P10636 1/20 0.61
THRB P10828 1/20 0.61
PKM P14618 1/20 0.61
APEX1 P27695 1/20 0.61
BLM P54132 1/20 0.61
MCL1 Q07820 1/20 0.61
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
CYP3A4 P08684 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220073 1.00 ALDH1A1 (0.63) ALDH1A1KMT2AKDM4EGFERTP53
Hydrochloric Acid SCHEMBL4355655 0.98 KMT2A (0.64) ALDH1A1KMT2AKDM4EGFERTP53
Ammonia Solution, Strong SCHEMBL2320305 0.98 ALDH1A1 (0.61) ALDH1A1KMT2AKDM4EGFERTP53
Nitrogen SCHEMBL28649205 0.96 ALDH1A1 (0.59) ALDH1A1KMT2AKDM4EGFERTP53
Aminobenzoic Acid SCHEMBL10434210 0.88 KMT2A (0.58) ALDH1A1KMT2AKDM4EGFERTP53
SCHEMBL28356361 0.85 RECQL (0.73) ALDH1A1KMT2AKDM4EGFERTP53
SCHEMBL9540049 0.84 RECQL (0.79) ALDH1A1KMT2AKDM4EGFERTP53
SCHEMBL5707631 0.83 RECQL (0.56) ALDH1A1KMT2AKDM4EGFERTP53
SCHEMBL128885 0.83 SMN1; SMN2 (0.63) ALDH1A1KMT2AKDM4EGFERTP53
SCHEMBL620233 0.83 RECQL (0.59) ALDH1A1KMT2AKDM4EGFERTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064449-A1 TOPICAL COMPOSITIONS AND USES OF PAI-1 INHIBITORS EIRION THERAPEUTICS, INC. (US) 2025-03-27 WO claimed